Nav: Home

Study shows how H. pylori causes white blood cells to morph

March 09, 2017

Researchers with the Iowa City Veterans Affairs Health Care System and University of Iowa have produced striking new evidence of neutrophil plasticity, or the ability of these white blood cells to change their properties.

The scientists exposed neutrophils -- the most prevalent white blood cells--to Helicobacter pylori bacteria, a common source of infection in the U.S. and worldwide, and the cause of stomach ulcers and other gastric problems. The lab experiments are among the first to show how mature white blood cells can change while still alive, in response to bacteria.

"Changes in neutrophil phenotype [observable traits] and function have been observed before, but only in vivo--such as in the circulation of sepsis patients, or in the joints of persons with arthritis," said study senior investigator Dr. Lee-Ann H. Allen. "However, previous attempts to reproduce these phenotypes using neutrophils isolated from human blood have not been successful. Thus, our study is the first to show that H. pylori infection, on its own, can alter the phenotype of human neutrophils."

Allen and her colleagues say the new findings may lead to a better understanding of how bacterial diseases arise in the body and how white blood cells respond. The scientists believe this may pave the way for new treatments, especially in the area of gastric health.

The results appeared March 1, 2017, in the Journal of Immunology.

Neutrophils are the most common white blood cells in the human body. The concepts of neutrophil plasticity and different neutrophil phenotypes--cells with different structural characteristics and functions-- have emerged only in the past few years. Previously, scientists thought these cells all had similar properties. But recent studies found different subsets of neutrophils in the body. However, no experiments until now were able to replicate the development of different neutrophil types in the lab.

In the new study, the Iowa researchers exposed neutrophils from human blood to H. pylori bacteria. H. pylori is a common bug that infects the human stomach. It can cause gastritis, peptic ulcers, and gastric cancer. H. pylori infection usually causes chronic inflammation, with a neutrophil-rich response from the immune system.

The neutrophil cells exposed to H. pylori underwent structural changes. The nucleus of a normal neutrophil cell usually has three or four interconnected lobes. But when infected with H. pylori, the neutrophil nuclei showed six or more lobes per cell.

Such "hypersegmentation" is rare in neutrophils. According to the researchers, it shows the bacteria are actively changing the neutrophils through a direct interaction.

Hypersegmentation was not seen when the researchers exposed eosinophils, a different type of white blood cell, to H. pylori. Also, the change only happened when neutrophils were directly infected with H. pylori, rather than when the bacteria were merely present. Neutrophils exposed to E. coli did not develop hypersegmentation, suggesting the change could be specific to H. pylori.

The phenotype change, rather than support a stronger immune response, appears to help the bacteria survive. Altered neutrophils do not kill H. pylori cells.

The bacteria also change the neutrophils in other ways, the study found. Normal neutrophils die as part of a natural process. But infected cells lived longer. The infected neutrophils also released molecules that are toxic to surrounding cells. When neutrophils are functioning normally, they produce chemicals called reactive oxygen species (ROS) around bacteria to kill the infection. H. pylori manipulates neutrophils so that they release ROS into the space outside the cells instead. This damages the stomach cells and helps the infection survive and spread.

The picture is not all bad, though. The changes brought on by H. pylori may also curtail gastric cancer. While H. pylori is classified as a carcinogen, it mainly causes gastritis and only rarely triggers ulcers or cancer. The hypersegmented neutrophils share some characteristics with tumor-associated neutrophils (TANs) in mice, found the study. Evidence suggests that abundant TANs are beneficial in human gastric cancer patients. So if the presence of this type of neutrophil really does limit tumor growth, it would help explain how H. pylori is able to chronically infect humans without resulting in gastric cancer in every patient. It also suggests that manipulating neutrophil phenotypes could possibly help treat gastric cancer.

The new study is the first lab demonstration of bacteria manipulating mature neutrophils. The authors say the work highlights the intriguing properties of these immune cells. They write, "Our findings are noteworthy as there is convincing evidence that [neutrophils] have multiple and potentially paradoxical roles in the development and progression of gastric disease."

The VA and University of Iowa researchers now plan to test other bacteria species to see if they have similar effects. The idea of neutrophil plasticity is still in its infancy, and the team says more research will lead to a better understanding how pathogens such as H. pylori interact with neutrophils or other white blood cells, and how the process can possibly be harnessed to fight disease.
The study was funded by the National Institutes of Health.

Veterans Affairs Research Communications

Related Cancer Articles:

Radiotherapy for invasive breast cancer increases the risk of second primary lung cancer
East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.
Cancer genomics continued: Triple negative breast cancer and cancer immunotherapy
Continuing PLOS Medicine's special issue on cancer genomics, Christos Hatzis of Yale University, New Haven, Conn., USA and colleagues describe a new subtype of triple negative breast cancer that may be more amenable to treatment than other cases of this difficult-to-treat disease.
Metabolite that promotes cancer cell transformation and colorectal cancer spread identified
Osaka University researchers revealed that the metabolite D-2-hydroxyglurate (D-2HG) promotes epithelial-mesenchymal transition of colorectal cancer cells, leading them to develop features of lower adherence to neighboring cells, increased invasiveness, and greater likelihood of metastatic spread.
UH Cancer Center researcher finds new driver of an aggressive form of brain cancer
University of Hawai'i Cancer Center researchers have identified an essential driver of tumor cell invasion in glioblastoma, the most aggressive form of brain cancer that can occur at any age.
UH Cancer Center researchers develop algorithm to find precise cancer treatments
University of Hawai'i Cancer Center researchers developed a computational algorithm to analyze 'Big Data' obtained from tumor samples to better understand and treat cancer.
New analytical technology to quantify anti-cancer drugs inside cancer cells
University of Oklahoma researchers will apply a new analytical technology that could ultimately provide a powerful tool for improved treatment of cancer patients in Oklahoma and beyond.
Radiotherapy for lung cancer patients is linked to increased risk of non-cancer deaths
Researchers have found that treating patients who have early stage non-small cell lung cancer with a type of radiotherapy called stereotactic body radiation therapy is associated with a small but increased risk of death from causes other than cancer.
Cancer expert says public health and prevention measures are key to defeating cancer
Is investment in research to develop new treatments the best approach to controlling cancer?
UI Cancer Center, Governors State to address cancer disparities in south suburbs
The University of Illinois Cancer Center and Governors State University have received a joint four-year, $1.5 million grant from the National Cancer Institute to help both institutions conduct community-based research to reduce cancer-related health disparities in Chicago's south suburbs.
Leading cancer research organizations to host international cancer immunotherapy conference
The Cancer Research Institute, the Association for Cancer Immunotherapy, the European Academy of Tumor Immunology, and the American Association for Cancer Research will join forces to sponsor the first International Cancer Immunotherapy Conference at the Sheraton New York Times Square Hotel in New York, Sept.

Related Cancer Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#SB2 2019 Science Birthday Minisode: Mary Golda Ross
Our second annual Science Birthday is here, and this year we celebrate the wonderful Mary Golda Ross, born 9 August 1908. She died in 2008 at age 99, but left a lasting mark on the science of rocketry and space exploration as an early woman in engineering, and one of the first Native Americans in engineering. Join Rachelle and Bethany for this very special birthday minisode celebrating Mary and her achievements. Thanks to our Patreons who make this show possible! Read more about Mary G. Ross: Interview with Mary Ross on Lash Publications International, by Laurel Sheppard Meet Mary Golda...